‘Proteolytic switching’: opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
Open Access
- 9 April 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (3), 504-512
- https://doi.org/10.1038/sj.bjc.6690385
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3Journal of Biological Chemistry, 1997
- Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinicSeminars in Cancer Biology, 1996
- MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularizationDevelopmental Brain Research, 1995
- Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinasesProgress in Growth Factor Research, 1995
- Protease inhibitors: Role and potential therapeutic use in human cancerEuropean Journal Of Cancer, 1994
- Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitorInternational Journal of Cancer, 1994
- Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblastsFEBS Letters, 1990
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989
- Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-βScience, 1987
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976